Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 44.02----

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH is 44.02 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202444.02
Mar2023-
Mar2022-
Mar2021-
Mar2020-

How is Price to Cash Earnings (PCE) of CONCORD BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 44.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0
0
Mar2020 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹17,540.4 Cr -3.9% -28.5% 19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-3.9%

-28.5%

19.5%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses